CRH, the Irish building materials group, is moving to buy Arcosa, a Dallas-based infrastructure products company, in a deal valued at roughly $8.5 billion. Multiple reports describe the transaction as all-cash and centered on CRH seeking a larger footprint in the United States amid a construction upcycle. Terms reported across outlets put the consideration around $8 billion to $8.5 billion, with Quartz specifying an $8.5 billion figure and a price of $150 per share. Quartz reports this per-share price represents about a 25% premium to Arcosa’s 60-day average share price, indicating the acquisition is offered at a significant uplift versus recent trading levels. Other coverage characterizes the transaction as CRH “digging deep” to secure a bigger share of US construction-related demand, framing the bid as strategically aligned with expanding CRH’s US operations. The reported deal size and cash nature are consistent across sources, while detailed timing—such as signing versus closing—appears less emphasized in the excerpts provided.
CRH to acquire Arcosa in about $8.5 billion all-cash deal
CRH, the Irish building materials group, is moving to buy Arcosa, a Dallas-based infrastructure products company, in a deal valued at roughly $8.5 billion. Multiple reports describe the transaction as...
- CRH is pursuing an acquisition of US-based infrastructure products firm Arcosa.
- Reports value the deal at about $8 billion to $8.5 billion.
- The transaction is described as all-cash.
- Quartz reports a price of $150 per Arcosa share.
- Quartz says the offer is about a 25% premium to Arcosa’s 60-day average price.
Irish building materials group’s deal for Arcosa is worth doing
2 months agoThe building materials giant is paying $150 per share for the Dallas-based infrastructure products company, a 25% premium to its 60-day average price
2 months ago
EquipmentShare.com faces securities class action over alleged investor losses
EquipmentShare.com Inc. (NASDAQ: EQPT) is named in multiple securities class action lawsuits alleging violations of U.S....
Capricor Therapeutics Faces Securities Class Action; Lead Plaintiff Deadline Set for Sept. 28, 2026
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is facing a securities class action alleging violations of federal securities...
Dodgers keep Shohei Ohtani off the mound due to lingering left knee soreness
The Los Angeles Dodgers remove Shohei Ohtani from pitching as he manages a lingering left knee issue. Multiple reports s...